Yichang Humanwell Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is REMIFENTANIL HYDROCHLORIDE, with a corresponding US DMF Number 33151.
Remarkably, this DMF maintains an Active status since its submission on September 21, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 21, 2019, and payment made on September 28, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II